Deena Chauhan

Experience

• 

  Deutsche Bank

  Jan 2004 - Jan 2005

  Fixed Income, Global Markets

  Client Advisor for Deutsche Bank Index Quant platform. 1 year internship pre-university, youngest full time employee in London office (age 18).

• 

  Goldman Sachs

  Jan 2008 - Aug 2010

  Commodity Sales

  Cross-commodities risk management for clients

• 

  HSBC

  Jan 2010 - Jan 2023

  Chief of Staff to Global Head and Executive Committee. Designed and executed significant strategic growth initiatives. Multi-asset investment specialist advising HNW, UHNW and Family Offices on discretionary portfolio solutions. Hired into HSBC’s elite International Management Programme, reserved for the top 1% of talent with global postings and sponsorship.Focus on execution of business strategy, customer growth and investment product development

  • Chief of Staff, Global Investment Wealth Solutions

    Jan 2020 - Jan 2023

  • Director, Managed Investment Solutions

    Jan 2017 - Jan 2020

  • International Manager

    Jan 2010 - Jan 2017
• 

  Various

  Jan 2023 - now

  Strategic Advisor

  Strategic Advisor to various pre-seed startups:- Kansoskin : DTC skincare brand founded in 2019, specializing in a single moisturiser for sensitive skin that combines Asian rituals with modern science. Available in Singapore, the US, and the Philippines. - Sociosight: A social management and marketing tool designed to help businesses and influencers in Indonesia elevate their brand and connect more effectively with their target audience on social media.

• 

  Cyclomeds

  Jan 2023 - Jan 2023

  CEO & Co-Founder

  Cyclomeds was selected to be part of the National University of Singapore (NUS) Research Innovation Programme, a deep tech incubator and successfully raised seed funding.A mission driven deep medtech startup, to improve the lives of 250m+ Lymphedema patients globally. Lymphedema affects c.1/3 of breast cancer patients post treatment causing limb swelling and immobility. There is currently no cure available on the market.Cyclomeds has developed a breakthrough solution to reverse the symptoms of Lymphedema, it is a spin-off from academia - backed by 20+ years of research, 21 research publications, $3m R&D spend and patent filed in 7 jurisdictions. Co-founding team from academia and business. Show less

• 

  EWD

  Jan 2024 - Jan 2024

  CEO & Co-Founder

  A materials science startup developing a new class of bio-material that combines performance with true sustainability. Spin-off from A*STAR’s Institute of Materials Research and Engineering (IMRE), backed by funding from A*STAR’s Venture and Innovation Group. Co-founding team brings expertise in materials science and business. Our patented platform technology, developed over 5+ years of R&D, transforms food waste into high-value medical, biomaterials and engineering composites by modifying bacterial cellulose films for various applications. Our first product, bio-leather made from bacterial cellulose, offers a high-quality, affordable alternative to traditional plastics and animal-derived materials. With up to 95% biomass content, our biodegradable and circular bio-leather can be efficiently scaled and seamlessly integrated into existing manufacturing systems, ensuring a positive economic and environmental impact.We are committed to driving the next-generation materials revolution and envision a future where sustainable materials are accessible to all. Show less